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Staphylococcus aureus is a leading cause of both nosocomial and
community-acquired infection. Biofilm formation at the site of infec-
tion reduces antimicrobial susceptibility and can lead to chronic infec-
tion. During biofilm formation, a subset of cells liberate cytoplasmic
proteins and DNA, which are repurposed to form the extracellular
matrix that binds the remaining cells together in large clusters. Using
a strain that forms robust biofilms in vitro during growth under glu-
cose supplementation, we carried out a genome-wide screen for genes
involved in the release of extracellular DNA (eDNA). A high-density
transposon insertion library was grown under biofilm-inducing condi-
tions, and the relative frequency of insertions was compared between
genomic DNA (gDNA) collected from cells in the biofilm and eDNA
from the matrix. Transposon insertions into genes encoding functions
necessary for eDNA release were identified by reduced represen-
tation in the eDNA. On direct testing, mutants of some of these
genes exhibited markedly reduced levels of eDNA and a concom-
itant reduction in cell clustering. Among the genes with robust
mutant phenotypes were gdpP, which encodes a phosphodies-
terase that degrades the second messenger cyclic-di-AMP, and
xdrA, the gene for a transcription factor that, as revealed by
RNA-sequencing analysis, influences the expression of multiple
genes, including many involved in cell wall homeostasis. Finally,
we report that growth in biofilm-inducing medium lowers cyclic-
di-AMP levels and does so in a manner that depends on the gdpP
phosphodiesterase gene.
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Biofilms are communities of microbial cells that are generallyattached to a surface and are held together by an extracel-
lular matrix. Matrix components are often produced by the cells
that make up the biofilm and serve as a natural glue, connecting
neighboring cells to one another. Biofilms formed by pathogens,
including Staphylococcus, have been shown to contribute to the
recalcitrance of infections, in part due to enhanced antibiotic
tolerance conferred by the matrix itself, which can reduce pen-
etration of antimicrobial agents (1, 2).
Bacteria use a variety of strategies to form biofilms, and even
among Staphylococcus aureus, different strains use distinctive
strategies. Antibiotic resistance appears to be linked to biofilm-
formation, with methicillin-sensitive S. aureus (MSSA) strains
more likely to require the polysaccharide intercellular adhesin
(PIA), whose production is governed by the ica operon, whereas
methicillin-resistant S. aureus (MRSA) strains most often form
biofilms in a PIA-independent, glucose-dependent manner (3).
Here, we report the identification of genes that are important for
the release of extracellular DNA (eDNA) in biofilms formed by a
strain of S. aureus [HG003, a virulent derivative of multilocus se-
quence type (MLST) ST8 strain NCTC8325 repaired for two reg-
ulatory genes; ref. 4], which is MSSA, but forms ica-independent
biofilms similarly to MRSA strains.
We have shown that the major components of the biofilm
matrix of HG003 are proteins and eDNA, which associate with
the biofilm in a manner that depends on a drop in pH during
growth in the presence of glucose (5, 6). Many of these proteins
are cytoplasmic in origin and are thus moonlighting in their
second role as components of the biofilm matrix (5). These
moonlighting proteins do not depend on eDNA to remain as-
sociated with cells. The eDNA, however, requires the presence
of matrix proteins to adhere to the cells, serving as an electro-
static net that holds cells together in large clumps (6). eDNA is a
critical component of the matrix of the HG003 staphylococcal
biofilm, because DNase I treatment of biofilm cells leads to a
marked reduction in clumping and a partial reduction in biofilm
biomass (6).
How components of the biofilm matrix are externalized remains
to be fully understood. Lysis of a subset of cells seems a likely
candidate, and mutants defective in autolysis have been found to
have reduced biofilm formation ability in some PIA-independent
strains (7). Other known mechanisms of eDNA release include
prophage-mediated cell death (8), and lysis-independent methods
such as vesicle formation (9) or specialized secretion (10). It is
possible that one or more of these release mechanisms contributes
to the externalization of S. aureus biofilm matrix components.
Here, we sought to identify genes required for the release of
eDNA by using a comprehensive genome-wide transposon-
sequencing approach. We took advantage of an earlier observation
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that the eDNA component of the biofilm matrix is released into the
medium when the cells are suspended in a buffer at a higher pH (6).
This method enabled us to separate eDNA in the matrix from ge-
nomic DNA (gDNA), which we extracted from cells in the biofilm.
We report the identification of several genes in which transposon
insertions were underrepresented in eDNA, compared with their
occurrence in gDNA. Upon direct testing, mutants of some of these
genes were markedly defective in eDNA release and cell clumping
during biofilm formation. Among these genes were gdpP, which
encodes a phosphodiesterase that acts on the second messenger
cyclic-di-AMP, and xdrA, which encodes a transcription factor that
had not previously been implicated in biofilm formation. We further
show that growth under glucose supplementation, which is required
for biofilm formation, lowers cyclic-di-AMP levels in wild-type cells
but not in a gdpP mutant.
Results
Comprehensive Strategy for Identifying Genes Involved in eDNA
Release. We used a high-density library of transposon insertions
in a biofilm-proficient strain of S. aureus (11) to screen for those
that impair release of eDNA and, hence, biofilm formation.
Under biofilm-inducing conditions, extracellular complementa-
tion would mask insertions that fail to contribute eDNA because
these mutants would be retained in the biofilm by virtue of the
eDNA released by other cells in the population. To circumvent
this problem, we took advantage of a prior observation that
mature biofilms release their matrix, including the eDNA com-
ponent, when the cells are suspended at a neutral pH (7.5) buffer
(6). We therefore grew a biofilm using a mixed inoculum rep-
resenting a highly saturated transposon library and proceeded to
isolate eDNA recovered by neutralization of the biofilm envi-
ronment. gDNA was then extracted from cells in the biofilm that
had been freed from the eDNA, and the frequency of transposon
insertion in or near various genes was compared between the two
DNA samples. We reasoned that transposon insertions in genes
involved in the release of eDNA would be underrepresented in
eDNA compared with gDNA (Fig. 1A).
Identification of Transposon Insertions in Genes Underrepresented in
eDNA. Cells of the pooled mutant library were grown under
biofilm-inducing conditions, and biofilms were harvested at 6 and
8 h. Preliminary studies had indicated that eDNA release is at its
peak during this window (12). Because of the potential risk of
population bottlenecks stemming from varying representation of
the mutant library in different experiments, the experiment was
repeated at both time points. eDNA and gDNA were isolated from
biofilms, and sites of transposon insertions were sequenced and
identified. The relative number of reads corresponding to each
insertion was compared between the eDNA and gDNA samples
(Fig. 1B). We identified 36 genes that possessed significantly more
transposon insertions (q value of less than 0.05) in the gDNA than
in the biofilm-associated eDNA (Fig. 1C), in one or more of the
transposon construct categories (all, blunt, Perm, and other; Mate-
rials and Methods). These genes had, at minimum, a log2-fold
change of less than or equal to −1, and did not appear to be es-
sential (Table 1 and Dataset S1). In preliminary tests conducted to
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Fig. 1. Identifying genes involved in eDNA release. (A) Strategy overview: Cells of the HG003 transposon library were grown under biofilm-inducing con-
ditions and then separated into eDNA and biofilm cell fractions. DNA was extracted from the biofilm cells, representing gDNA. Sequencing reads from eDNA
and gDNA then were mapped to the genome, and the ratios of transposon insertions in eDNA and gDNA was computed for each gene. Shown in the hy-
pothetical example on the right, gene A has fewer transposon insertions in eDNA than in gDNA and is therefore potentially required for release of eDNA. In
contrast, gene B is not required for eDNA release. Henceforth, we focused on genes in category A. (B) Shown here is an example of a gene (apt) un-
derrepresented in reads per TA site in eDNA (Upper) compared with gDNA (Lower). The apt gene is flanked by regions of the chromosome highlighted in
gray, which show little to no differential representation of reads. (C) Volcano plot showing all transposon screen results. The x axis displays log2-fold change,
and the y axis displays the negative log10 of the q value (those genes with 0 q value were given a value of 0.001 for plotting purposes). Genes with log2-fold
change ≤ −1 and q < 0.05, which did not appear to be essential based on the frequency of transposon insertions, are highlighted in red.
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optimize conditions, which used a lower density transposon in-
sertion library (13), eight of the genes listed in Table 1 (alsT, fmtA,
ptsI, SAOUHSC_00034, recF, tcyA, ansA, and lpl2A) were also
identified by using the same cutoff criteria.
Several genes identified in this eDNA release screen are in-
volved in nucleotide metabolism. These genes include apt and
upp, which enable nucleotide salvage reactions, and purR, which
encodes a repressor of de novo purine synthesis (14). Disruption
of any of these three genes would lead to increased de novo
nucleotide synthesis. We also identified another gene involved in
purine nucleotide metabolism, gdpP, which encodes a phospho-
diesterase that cleaves the second messenger cyclic-di-AMP (15).
Additionally, members of the pyruvate dehydrogenase complex
pdhA, pdhB, and pdhC were identified, disruption of which could
lead to an increase in pyruvate metabolism by pyruvate formate
lyase (Pfl), thereby increasing cellular formate levels. Formate
produced by Pfl is used to generate formyl-THF and methenyl-
THF, both of which are precursors for purine metabolism.
A second category of genes was those involved in glycoly-
sis and respiration, mutations of which would enhance anaer-
obic respiration and fermentation. These genes include those
for components of ATP synthase, CcpA (16), Rex (17), and
SrrA (18).
Finally, we note that our dataset also yielded genes that were
overrepresented for transposon insertions in the eDNA, with a
log2-fold change of greater than or equal to 1 (Dataset S2).
Mutants of Genes Underrepresented for Transposon Insertions Exhibit
Reduced Levels of eDNA. Next, we asked whether the genes identi-
fied in our screen are needed for the release of eDNA during
biofilm formation when the mutants are grown individually in pure
culture. We constructed null mutants for nine of these genes
(ΔyybS, ΔfmtA, Δ1025, ΔalsT, ΔansA, Δapt, ΔccpA, ΔxdrA, ΔgidA)
in the present work, and also used a previously generated mutant
(ΔsarA) (6). Additionally, a transposon insertion in an 11th gene,
gdpP, was recovered by using a strategy described below.
Quantitative measurements of eDNA released from these
strains revealed that in mature (24 h) biofilms, wild-type
HG003 released more eDNA than any of the deletion mu-
tants, among which eDNA release varied widely (Fig. 2, Upper).
In sum, we observed a slight reduction in eDNA levels in ΔansA,
ΔfmtA, ΔccpA, ΔalsT, ΔyybS, and ΔgidA mutants, and compar-
atively large reductions in eDNA release by Δ1025, ΔsarA,
ΔxdrA, Δapt, and gdpP::TnΩ1 mutants. These large reductions
were at or below the eDNA level observed following DNase I
treatment of wild-type biofilms (Fig. 2, Upper).
Table 1. Transposon insertions in genes underrepresented in eDNA
Functional category Locus tag Gene Product Log2-FC
Transporter SAOUHSC_01354 alsT Sodium:alanine symporter family protein −1.8
Transporter SAOUHSC_01028 ptsH Phosphocarrier protein HPr −1.7
Transporter SAOUHSC_01029 ptsI Phosphoenolpyruvate-protein phosphotransferase −1.3
Transporter SAOUHSC_00420 — Sodium-dependent transporter −1.3
Transporter SAOUHSC_00880 yuiF Putative amino acid transporter −1.2
Transporter SAOUHSC_02699 tcyA Hypothetical protein, putative L-cystine ABC transporter −1.2
Transporter SAOUHSC_00670 pitA Hypothetical protein, putative inorganic phosphate transporter −1.1
Transporter SAOUHSC_03037 vraE Bacitracin transport system permease protein −0.9*
Transporter SAOUHSC_00636 mntB Iron (chelated)/manganese ABC transporter permease −0.8*
Transcriptional regulator SAOUHSC_01979 xdrA Transcriptional regulator −1.8
Transcriptional regulator SAOUHSC_00620 sarA Accessory regulator A −1.6*
Transcriptional regulator SAOUHSC_01586 srrA DNA binding response regulator SrrA −1.6
Transcriptional regulator SAOUHSC_00034 — Hypothetical protein, putative transcriptional repressor −1.5
Transcriptional regulator SAOUHSC_01850 ccpA Catabolite control protein A −1.0
Transcriptional regulator SAOUHSC_02273 rex Redox-sensing transcriptional repressor Rex −0.9*
Glycolysis/TCA cycle SAOUHSC_00798 pgm Phosphoglyceromutase −1.4
Glycolysis/TCA cycle SAOUHSC_01042 pdhC Branched-chain alpha-keto acid dehydrogenase subunit E2 −1.2
Glycolysis/TCA cycle SAOUHSC_01040 pdhA Pyruvate dehydrogenase complex, E1 component subunit alpha −1.1
Glycolysis/TCA cycle SAOUHSC_01041 pdhB Pyruvate dehydrogenase complex, E1 component subunit beta −0.9*
Nucleotide metabolism SAOUHSC_01743 apt Adenine phosphoribosyltransferase −2.0
Nucleotide metabolism SAOUHSC_00467 purR Purine operon repressor −1.3
Nucleotide metabolism SAOUHSC_02353 upp Uracil phosphoribosyltransferase −1.1
ATP-synthase SAOUHSC_02341 atpD F0F1 ATP synthase subunit beta −1.1
ATP-synthase SAOUHSC_02346 atpH F0F1 ATP synthase subunit delta −1.0
ATP-synthase SAOUHSC_02343 atpG F0F1 ATP synthase subunit gamma −0.9*
Cell wall-related SAOUHSC_00998 fmtA Methicillin resistance protein FmtA −2.2
Cell wall-related SAOUHSC_01025 — Hypothetical protein −1.5
Other functions
Cyclic-di-AMP SAOUHSC_00015 gdpP Cyclic-di-AMP phosphodiesterase −1.7
Protein modification SAOUHSC_00575 lplA2 Octanoyl-[GcvH]:protein N-octanoyltransferase −1.4
tRNA modification SAOUHSC_03052 gidA tRNA uridine 5-carboxymethylaminomethyl modification enzyme −1.3*
Uncharacterized SAOUHSC_00755 — Hypothetical protein −1.2
Amino acid metabolism SAOUHSC_01497 ansA L-Asparaginase −1.0
Uncharacterized SAOUHSC_00014 yybS Hypothetical protein (just upstream of gdpP) −1.0
Uncharacterized SAOUHSC_03047 — Hypothetical protein −1.0
Integrase/recombinase SAOUHSC_03040 — Integrase/recombinase −0.9*
DNA repair SAOUHSC_00004 recF Recombination protein F −0.8*
Log2-FC, log2-fold change for the “All” comparison, which included all transposon constructs.
*Indicates that the cutoff criteria were not satisfied in this comparison (see Dataset S1 for full results).
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Previous studies have shown increased extracellular nuclease
production in a ΔsarA mutant background, which contributes to
reduced biofilm formation in this strain (19, 20). We spotted
cultures of our mutant strains onto DNase test agar plates to
determine whether enhanced extracellular nuclease levels could
be the cause of the reduction in eDNA levels. Only the ΔsarA
strain exhibited enhanced extracellular nuclease production
(Fig. S1).
Finally, we note that the 11 genes analyzed above represent
only a portion of the genes identified in our genome-wide screen
(Table 1). It will be interesting to see whether the as yet
uncharacterized genes also play a role in eDNA release.
A gdpP Mutation in a Different Genetic Background Also Causes
Reduced Levels of eDNA. The gdpP gene was of special interest
because of its role in controlling the levels of the second mes-
senger cyclic-di-AMP, which could act as a signaling molecule to
regulate biofilm formation. We therefore investigated the effect
of a gdpP deletion mutation in a different genetic background.
We used strain ANG1958 from the Gründling laboratory, which
was constructed in the RN4220 strain background and also
contains a Δspa mutation (15). Although RN4220 is from the
same parental NCTC8325 parental lineage as HG003 (4), it re-
leases less eDNA during biofilm formation than does HG003
(Fig. S2A, Upper, gray box). Nonetheless, the ΔgdpP, Δspa
mutant released significantly less eDNA than did RN4220. The
Δspa mutation in RN4220 was likely not responsible for this
effect, given that a Δspa mutant (gdpP+) derivative of HG003 was
unimpaired in eDNA release (Fig. S2A, Upper). We confirmed that
the gdpP mutation was responsible for reducing eDNA levels by
complementing both the transposon insertion mutation and the
deletion mutation with a wild-type copy of gdpP under its native
promoter. The complemented gdpP mutant strains showed mark-
edly increased levels of eDNA over their parent strains (Fig. S2B,
Upper for ANG1958 and Fig. S3A, Upper for gdpP::TnΩ1). We
conclude that gdpP contributes to eDNA release and does so in two
different genetic backgrounds.
Mutants with a Large Reduction in eDNA Are Impaired in Biofilm
Formation. Along with measuring the levels and representation
of various insertion mutations in biofilm-associated eDNA, we
quantified the ability of the individual mutants to form biofilms.
As described, we grew various engineered null mutants under
biofilm-inducing conditions, and compared the optical densities
of the resuspended, washed biofilm, the recovered wash, and
medium fractions (5). Only four mutants, ΔsarA, ΔxdrA, Δapt,
and gdpP::TnΩ1, were found to produce reduced levels of
biofilm in monoculture (Fig. 2, Lower). Strains harboring
ΔsarA, ΔxdrA, Δapt, and gdpP::TnΩ1 exhibited the most severe
impairment in eDNA release relative to the HG003 parental
strain. This observation indicates that reduction below a
threshold of ∼25% of the wild-type level of eDNA release is
required to significantly reduce biofilm formation in
HG003 under the conditions of our experiments. We also
conclude that biofilm formation, as judged by the OD600 of
washed biofilms, is only partially impaired even when eDNA is
reduced to low levels. In particular, the Δapt mutant released
less than 2% of the amount of eDNA as that by the wild-type
parental strain, but still formed a biofilm of 60% of the optical
density of the wild-type biofilm–the same level that was seen
with DNase I treatment (Fig. 2, Lower).
The ANG1958 ΔgdpP mutant also showed a partial reduction
in biofilm formation relative to its parent RN4220 (Fig. S2A,
Lower), and biofilm formation was restored by complementation
(Fig. S2B, Lower).
Cell Clumping Is Markedly Reduced in Low-eDNA Mutants. Whereas
reduced eDNA release only results in a modest reduction in
biofilm formation, as inferred from turbidity measurements, it
has a profound effect on cell clumping, as judged by microscopic
examination of DNase I-treated biofilms (6). We therefore hy-
pothesized that mutants that liberate reduced eDNA levels
would similarly show a marked reduction in clumping. To in-
vestigate this hypothesis, mutants defective in eDNA release
were grown under biofilm-inducing conditions, concentrated by
centrifugation, and gently resuspended in a smaller volume of
the remaining spent medium before imaging. During initial
concentration of the cells, the wild-type cell pellet was notably
more diffuse than the other pellets, which were compact (Fig.
S4). This result is akin to the phenotype seen in traditional ag-
glutination assays, in which agglutinated erythrocytes or yeast
cells form diffuse pellets, whereas nonagglutinated cells form
compact pellets (21, 22). Imaging revealed that the wild-type
cells were in large clumps, whereas the mutant cells and DN-
ase I-treated cells were in much smaller clumps (Fig. 3).
Clumping was dramatically reduced for the four mutant deriva-
tives of HG003 that were most reduced in eDNA release: Δapt,
gdpP::TnΩ1, ΔxdrA, and ΔsarA. These results are consistent with
Fig. 2. Quantification of eDNA and biofilm formation by wild-type and
mutant cells. Upper shows eDNA quantification normalized to wild-type
HG003 levels, in order of increasingly severe effects on eDNA levels. Lower
shows absolute biofilm quantification for biofilms collected 24 h after in-
oculation by the indicated mutants, or by HG003 with DNase I treatment.
Significant differences were calculated with Student’s t test, comparing to
wild type in each case. For eDNA, ΔansA had a P ≤ 0.01, and all other strains
had P ≤ 0.0001. For resuspended biofilm measurements, the reductions
observed upon DNase I treatment, and for ΔsarA, ΔxdrA, gdpP::TnΩ1, and
Δapt, were significant, with P ≤ 0.0001.
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the idea that eDNA serves as an electrostatic net that links cells
together in biofilm formation.
Resistance to Congo Red Is Enhanced in Mutants with Reduced eDNA.
To investigate the possibility that the products of the genes
identified in this study impair cell wall integrity, possibly resulting
in cell lysis as a means for the release of eDNA, we investigated
the sensitivity of the mutants to the dye Congo red. We found that
wall teichoic acids protect S. aureus against lysis by Congo red and
other dyes (23), and we reasoned that potential differences in the
cell walls of eDNA-release defective mutant strains could alter
Congo red susceptibility. Serial dilutions of wild-type HG003 and
its mutant derivatives were spotted onto agar plates containing
tryptic soy broth (TSB), with or without Congo red, and incubated
overnight. Some mutants (Δspa, ΔfmtA, and ΔsarA) exhibited
similar levels of sensitivity to Congo red as the wild type, or en-
hanced sensitivity (Δ1025, ΔgidA, ΔccpA, ΔansA), whereas others
showed a slight increase in Congo red resistance (ΔyybS, ΔalsT)
(Fig. S5). Interestingly, the three mutations causing the greatest
defect in eDNA release (Δapt, gdpP::TnΩ1, and ΔxdrA) caused
conspicuous resistance to Congo red (Fig. 4). These findings are
consistent with the hypothesis that these genes, when functional,
cause cell envelope alterations that impair cell wall integrity,
presumably resulting in cell lysis.
The ΔgdpP mutant ANG1958 also exhibited resistance to
Congo red compared with RN4220 (Fig. S2C) and in a manner
that was reversed by complementation (Fig. S2D), as was the
case for the gdpP::TnΩ1 strain (Fig. S3B).
Resistance to Congo Red Can Be Used To Isolate Insertions Mutations
in gdpP. The observation that certain mutants defective in eDNA
release exhibited Congo red resistance provided a strategy for
isolating additional mutants of the genes in this study. We de-
termined that a Congo red concentration of 0.25% prevents
growth of wild-type HG003 but allows strains with high Congo red
resistance to survive. We then plated out the transposon insertion
Lower magnification Higher magnification
∆xdrA
∆apt
+ DNase I
Wild Type
∆sarA
gdpP::TnΩ1
Fig. 3. Cell clumping is reduced in mutants with reduced eDNA. Twenty-
four-hour biofilms were grown by using wild-type HG003 and mutant de-
rivatives most deficient in eDNA release, cells were resuspended in spent
medium and imaged. HG003 with DNase I treatment is shown for compar-
ison. Scale bars in the lower right corner of DNase I images are 15 μm wide
in the higher magnification image and 200 μm wide in the lower magnifi-
cation image.
Fig. 4. Mutants with reduced eDNA display enhanced resistance to Congo
red. Overnight cultures of the wild-type strain HG003 and its mutant de-
rivatives were serially diluted, spotted onto agar plates with or without 0.1%
Congo red, incubated overnight, and imaged.
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library on plates containing this high Congo red concentration and
sequenced the sites of insertion by using random nested primer
amplification. Among the insertions so identified were several in
gdpP. One such insertion mutation, gdpP::TnΩ1, which harbored
an insertion at the TA site located at codon 183 (TAC), was used
in the experiments of Figs. 2–4 and Figs. S1 and S3–S6.
Growth Under Glucose Supplementation Lowers Cyclic-di-AMP Levels
in a gdpP-Dependent Manner. The discovery that gdpP is required
for eDNA release prompted us to measure cyclic-di-AMP levels
during biofilm formation by using HPLC. We carried out these
measurements with wild-type (HG003) cells and gdpP::TnΩ1
mutant cells collected at 8 and 24 h after growth in biofilm-
inducing medium that had or had not been supplemented with
glucose (Fig. S6). The results show that the levels of cyclic-di-AMP
were higher in wild-type cells grown in the absence of glucose or in
gdpP mutant cells than in wild-type cells grown under biofilm-
inducing conditions with glucose. These results together with
those presented above are consistent with the hypothesis that
eDNA release is triggered in part by a glucose-dependent drop in
cyclic-di-AMP levels.
xdrA Influences the Expression of Genes Involved in Biofilm Formation
and Virulence. Another gene of particular interest from our
genome-wide screen, xdrA, is known to encode a DNA-binding
protein with an XRE-family helix-turn-helix domain that directly
or indirectly activates the gene (spa) for protein A (24, 25). Given
our observations that an ΔxdrA mutant is impaired in eDNA re-
lease and biofilm formation, and the fact that a Δspa mutant was
not defective in eDNA release (Fig. S2A; ref. 5), it was of interest
to determine what other genes were influenced or regulated by
xdrA during biofilm formation. Accordingly, we performed RNA-
sequencing (RNA-seq) on wild-type (HG003) cells and ΔxdrA
mutant cells harvested during exponential phase in TSB medium,
exponential phase in TSB adjusted to the low (5.5) pH charac-
teristic of biofilm conditions, and early biofilm formation in TSB
supplemented with glucose. We observed significant changes in
transcript levels, both increases and decreases, for more than
100 genes when comparing the ΔxdrA mutant to wild-type cells.
Consistent with previous reports, we saw a reduction in spa tran-
script levels in ΔxdrAmutant cells during exponential growth (25),
and during biofilm formation and during growth at low pH. Only
one other gene (the small RNA transcribed from a region
downstream of SAOUHSC_00377) was similarly affected in all
conditions tested. Strikingly, most of the genes that showed sig-
nificant changes in transcript levels were differentially regulated
under one or both of the biofilm-relevant conditions but not under
conditions of exponential phase growth (Dataset S3).
To independently verify the results of RNA-seq, we performed
quantitative RT-PCR (qRT-PCR) on the 11 genes whose ex-
pression was altered to the greatest extent during biofilm for-
mation by the ΔxdrA mutation. Results of qRT-PCR confirmed
the direction and magnitude of change in most cases (Table 2).
Specifically, expression of spa, and an operon containing norB
(which encodes an efflux pump; ref. 26), steT, ilvA, and ald, were
reduced in the ΔxdrA mutant. Conversely, transcripts found in
increased abundance in the deletion mutant included those
encoded by the gene for δ-hemolysin (hld/RNA III); genes for
the β-phenol soluble modulins (PSMβs); a putative cold shock
gene, cspB; vraX, which encodes a protein that has not been well
characterized but shown to be highly up-regulated during cell
wall stress (27, 28); and genes for two hypothetical proteins,
SAOUHSC_00560 and SAOUHSC_00141.
The ΔxdrA mutation altered the expression of several additional
genes of interest. These genes include the transcriptional regulator
lysR, which appeared to be down-regulated in an ΔxdrA mutant
during biofilm formation, and tagG, encoding a wall teichoic acid
synthesis protein, which was up-regulated. Transcripts of mgrA
were also increased as measured by RNA-seq. MgrA is a regulator
of autolytic activity known to directly repress norB (whose reduced
transcription was also verified by qRT-PCR), and to activate abcA,
a gene encoding an ATP-binding protein that confers enhanced
resistance to cell wall-targeting antibiotics (29), and whose tran-
scription was increased in the ΔxdrA mutant. Also up-regulated in
the mutant strain were the genes for the α-phenol soluble modulins
(PSMαs), which are cotranscribed and are located in the region
between SAOUHSC_00411 and SAOUHSC_00412 (30). The agr
operon was up-regulated in the ΔxdrA strain not only under
biofilm-inducing conditions but also at low pH (as were the agr-
regulated PSMαs, PSMβs, and RNAIII genes), increasing our
confidence in this observation.
In addition to genes encoding known or suspected functions,
we identified changes in the level of transcripts of several less
well characterized genes (Dataset S3), including a small, non-
coding RNA (sRNA), transcribed from a region downstream of
SAOUHSC_00377, which is found in greater abundance in the
ΔxdrA mutant when grown in all three conditions tested. The
sRNA bears no extended sequence similarity to any other region
of the genome (Sequence: UACAAAUUCCCGGUAACCAU-
UCCGGCUUCAUUCUCUUGAAGAAUGACAUAUUCUC-
AGCGUUUUAGCUGAAGGUCAGAUGAUACGUCAUC-
TGGCCUCUUUUU). It is conserved within S. aureus, but not
found in other species as determined by National Center for
Biotechnology Information (NCBI) BLAST. This sRNA has
Table 2. Verification of RNA-seq results by qRT-PCR
Locus tag Gene Product
Fold change
RNA-Seq qRT-PCR
SAOUHSC_00069 spa IgG binding protein A −41.7 −79.4 ± 32.8
SAOUHSC_01452 ald Alanine dehydrogenase −32.6 −16.1 ± 3.7
SAOUHSC_01451 ilvA Threonine dehydratase −21.8 −37.7 ± 8.6
SAOUHSC_01450 steT Amino acid permease −16.8 −20.3 ± 2.1
SAOUHSC_01448 norB Drug resistance MFS
transporter
−12.8 −5.1 ± 0.1
SAOUHSC_02260 hld/ RNAIII δ-hemolysin 8.7 3.1 ± 0.2
SAOUHSC_03045 cspB Cold shock protein 5.8 1.2 ± 0.2
SAOUHSC_01136 psmβ Phenol soluble modulin
class beta
6 4.9 ± 1.1
SAOUHSC_00561 vraX Involved in cell wall stress 5.3 1.8 ± 0.7
SAOUHSC_00560 — Hypothetical protein 4.5 1.2 ± 0.3
SAOUHSC_00141 — Hypothetical protein 6.1 8.5 ± 0.8
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been identified in previous large-scale transcriptome studies as
Teg146 (31), Sau-63 (32), and JKD6008sRNA83 (33).
Discussion
The goal of this investigation was to identify genes involved in
eDNA release during S. aureus biofilm formation. A challenge in
identifying such genes is that eDNA becomes a community good
that is shared by the population, and mutants with lesions in
these genes would be predicted to be rescued by extracellular
complementation. We therefore devised a strategy that allowed
us to identify genes interrupted by transposon insertions, in
which insertions were underrepresented in eDNA compared
with gDNA contained within biofilm cells. This approach
allowed us to screen a comprehensive library of transposon in-
sertions, reasoning that mutant cells harboring such defects in
eDNA externalization would be underrepresented in the eDNA
recovered from the biofilm matrix (Fig. 1). The findings of this
screen were then validated by showing that null mutants in genes
so identified were impaired in the release of eDNA. These mu-
tants varied widely in the extent of eDNA release impairment,
with the most severely impaired mutants releasing eDNA at levels
below a threshold needed for robust biofilm formation (Fig. 2). In
particular, mutants of sarA, xdrA, apt, and gdpP had eDNA levels
at or below those observed following DNase I treatment and were
correspondingly impaired in biofilm formation. Mutation of sarA
is known to cause overproduction of extracellular nucleases (19,
20), providing a simple explanation for its reduced eDNA phe-
notype but little insight into the mechanism governing eDNA
release. The xdrA, apt, and gdpP mutations, in contrast, had little
or no effect on nuclease secretion (Fig. S1), raising the possibility
that one or more of these genes is directly involved in controlling
eDNA release during biofilm formation.
We do not know the mechanism by which eDNA is released,
but a simple possibility is that cells undergoing biofilm formation
selectively lyse because of impaired cell envelope integrity,
thereby releasing gDNA into the matrix. Interestingly, the mu-
tants with the most severe reductions in eDNA release (ΔxdrA,
Δapt, and gdpP::TnΩ1) exhibited enhanced resistance to Congo
red (Fig. 4), which is known to induce lysis of mutants with cell
envelope defects (23). Mutants that are impaired in lysis would
therefore be expected to exhibit resistance to Congo red, and we
speculate that the ΔxdrA, Δapt, and gdpP::TnΩ1 mutants are
defective in eDNA release because they maintain cell wall in-
tegrity under biofilm-inducing conditions. It should be noted,
however, that this mechanism is evidently distinct from other
known pathways of cell lysis; mutations in genes previously im-
plicated in cell lysis [specifically ΔcidA (34), Δaaa (35), and Δatl
(36, 37)] had little or no effect on eDNA release under our
biofilm-inducing conditions (6).
The most intriguing gene to emerge from our study is gdpP, which
encodes a phosphodiesterase that cleaves the second messenger
cyclic-di-AMP (15). Deletion of gdpP (which elevates intracellular
cyclic-di-AMP levels) has been shown to increase peptidoglycan
cross-linking, enable survival without lipoteichoic acid, enhance re-
sistance to cell envelope-targeting antibiotics, and promote acid tol-
erance in S. aureus (15, 38). High levels of cyclic-di-AMP have been
linked to increased transcript levels of pbp4, a penicillin binding
protein, which could explain the increase in peptidoglycan cross-
linking (39). In B. subtilis, cyclic-di-AMP plays a role in
peptidoglycan homeostasis and its depletion promotes cell lysis
(40), suggesting that regulation of wall integrity may be a broadly
conserved role for cyclic-di-AMP. Together with the findings of our
investigation, this prior work suggests a model in which cyclic-di-
AMP levels drop under biofilm-inducing conditions, impairing cell
wall integrity and triggering cell lysis. In support of this model, we
have shown that growth under glucose supplementation lowers cyclic-
di-AMP levels and that a gdpP mutation leads to increased levels of
the second messenger.
Our model offers a possible explanation for the role of apt,
which encodes a purine salvage enzyme, adenine phosphoribosyl-
transferase. Deletion of apt (or of purR, also identified in our
screen) would enhance de novo purine nucleotide synthesis, con-
ceivably preventing the drop in cyclic-di-AMP levels. It will be in-
teresting to see whether and how Δapt influences cyclic-di-AMP
levels under biofilm-inducing conditions.
Also of special interest is xdrA, which encodes a DNA-binding
protein that binds the methicillin resistance mecA promoter re-
gion (24). Deletion of xdrA is known to increase resistance in
several methicillin-resistant clinical isolates. Using RNA-seq, we
found that deletion of xdrA increased expression of the agr
quorum sensing system and the downstream PSM genes, which
have been linked both to biofilm dispersal and stability (41–43).
We also found higher expression levels of genes involved in cell
envelope synthesis and stress response. It could be that the
ΔxdrA strain induces the cell wall stress stimulon, as evidenced
by higher vraX levels (27, 28), which in turn contributes to in-
creased cell envelope strength and reduced lysis and, hence,
reduced eDNA.
Interestingly, an sRNA was also found to be highly overex-
pressed in the ΔxdrAmutant. This sRNA has been found to show
altered expression in a small colony variant of S. aureus isolated
from a chronic osteomyelitis infection (32). Small colony variants
of S. aureus have been found to have thick cell walls (44, 45), and
this sRNA could additionally contribute to the reduced lysis
phenotype we observe in ΔxdrA.
Together, our analysis identified xdrA as a transcriptional
regulator that directly or indirectly modulates the expression of
genes that control cell wall stability, quorum sensing, and biofilm
dispersal under biofilm-inducing conditions. It will be of interest
to see which genes under XdrA control are needed for eDNA
release and whether they act upstream, downstream, or in-
dependently of cyclic-di-AMP.
In sum, we have identified previously unrecognized genes that
contribute to eDNA release and biofilm formation. Our results
implicate a reduction in cyclic-di-AMP levels in triggering eDNA
release via impaired cell wall homoeostasis. The products of the
genes that we have identified provide potential targets for future
therapies designed to dissociate or prevent the formation of
staphylococcal biofilms. Also, our strategy of identifying genes in
which transposon insertions are underrepresented into eDNA
could be applicable to identifying genes involved in the release of
extracellular DNA in other biofilm-forming bacteria.
Materials and Methods
Strains and Growth Conditions. The bacterial strains used in this study are
listed in Table S1. S. aureus was maintained in tryptic soy broth (TSB; EMD
Millipore) and on LB agar (BD). S. aureus biofilms were grown in TSB sup-
plemented with 0.5% glucose (TSB-G). Escherichia coli DC10B was main-
tained in LB and on LB agar. Selection for drug-resistant strains was carried
out by using 3 μg/mL tetracycline, 10 μg/mL erythromycin, or 10 μg/mL
chloramphenicol for S. aureus, and 100 μg/mL ampicillin for E. coli.
Transposon-Insertion Screen. The transposon insertion experiment was per-
formed by using an ultra-high density library in the HG003 strain background
(11). A frozen aliquot of the library was added to a small volume of TSB.
After 1 h of growth at 37 °C, this preculture was used to inoculate fresh TSB-G
to an OD600 of 0.01. Three hundred milliliters of this culture was added to
large volume dishes (no. 166508; ThermoFisher) and incubated statically at
37 °C for 6 or 8 h. The medium was aspirated, and the remaining adherent
cells were resuspended in PBS at pH 7.5 by using pipetting and cell scrapers.
Following a brief incubation in PBS, biofilm cells were pelleted by centrifu-
gation for 10 min at 7,000 × g at 4 °C, and the supernatant was removed and
filtered by using an Acrodisc 25-mm syringe filter with 0.2-μm HT Tuffryn
membrane (PN 4192, Pall) or using a 0.22-μm filter system (431098, Corning).
gDNA from the biofilm cells was extracted from the pelleted biofilm cells by
using the Wizard Genomic DNA Purification Kit (A1120m Promega). eDNA
from the matrix was precipitated from the supernatant by adding 1/10 of
the supernatant volume of 3 M NaOAc at pH 5.0 and isopropanol to a final
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concentration of 30%. This mixture was incubated overnight at −20 °C and
centrifuged for 15 min at 24,000 × g at 4 °C. The pellet was washed with
75% ice cold ethanol, air dried, and resuspended in 400 μL of water.
Extracted eDNA and gDNA were then RNase treated by using 1 U RNase H
(Roche) per ∼50 μg of gDNA or 5 μg of eDNA for 15 min at 37 °C. The DNAs
were purified by extraction with phenol-chloroform and run over a DNA
purification column (D4065, Zymo Research) according to manufacturer’s
guidelines. Sample preparation for next generation sequencing and map-
ping of reads to TA sites were performed as described (11). Sequencing was
performed on an Illumina HiSEq 2500 at the Tufts University Core Facility.
Sequence Analysis. Spearman’s rank correlation coefficients were calculated
by using read count per gene for the different replicates and time points
(Fig. S7). Our final analysis compared results from 6-h and 8-h time points in
combination, because we expected that eDNA release was occurring
throughout this time period and wanted to capture any relevant genes,
even those with a mild or delayed defect in eDNA release and to have
enough insertions to calculate significance even in genes with few TA sites.
Analysis of the transposon-sequencing data were performed by using
TRANSIT (46). Resampling comparative analysis of eDNA to gDNA samples
was performed with 10,000 permutations by using trimmed total reads
normalization and LOESS genome positional bias correction. Genes of in-
terest were identified as those with a log2-fold change of less than or equal
to −1, a false discovery rate of less than 5% (q < 0.05), and a (number of
normalized transposon counts)/(TA sites hit) greater than 1 for the count
average across eDNA and gDNA. Because the library consisted of six trans-
poson constructs, we ran our analysis on four promoter categories: all (all
transposons), blunt (promoterless), Perm (weakest promoter), and other
(outward-facing promoters) (11).
Strain Construction. Strain SEJ1 gdpP::kan (ANG1958) was constructed in an
RN4220 Δspa background (15). Construction of unmarked deletion mutants in
HG003 was performed essentially as described (6) by using pKFC or pKFT
vectors (47). Plasmids pASD132 and pASD145 (empty vectors) were generated
by using isothermal assembly of pCM29 (48) amplified with ASD226F and
ASD226R-2 (for pASD132), or pAH9 (41) amplified by using ASD234F and
ASD229R (for pASD145), to remove the fluorescent reporters. Plasmids
pASD135 and pASD133 (gdpP complementation constructs) were generated
by using isothermal assembly of the gdpP gene, the upstream gene, and their
native promoter with a backbone. For both, gdpP was amplified with primers
ASD227F-1 and ASD227R-1. For pASD133, the backbone was pCM29 digested
with PstI and EcoRI, and for pASD135, the backbone was pAH9 amplified with
ASD230F and ASD230R. Initial transformation of isothermal assembly products
was done in E. coli DC10B (49). Plasmid sequences were confirmed and plas-
mids were transformed directly into HG003 with appropriate selection. See
Table S2 for deletion construct details and Table S3 for primer sequences.
Quantitative Biofilm Assay.Overnight cultures of S. aureuswere grown in TSB
and diluted 1:1,000 into fresh TSB-G. For strains containing pASD135 or
pASD145, erythromycin was included. For strains containing pASD132 or
pASD133, chloramphenicol was included. Two hundred-microliter aliquots
of this inoculum were added in triplicate to wells of a Nunc MicroWell 96-
well plate (no. 167008; ThermoFisher) and incubated statically at 37 °C for
24 h. The medium was then carefully removed, and biofilms were washed
twice with 100 μL of PBS at pH 7.5. The washed biofilms were then resus-
pended in 200 μL of PBS at pH 7.5. The OD600 of these three fractions was
then measured by using a Bio-Tek Synergy II plate reader (BioTek Instru-
ments). Values from noninoculated wells with TSB-G or PBS alone were
subtracted from inoculated well readings, and averages and SDs calculated.
All biofilm assays were performed in triplicate a minimum of three times.
Quantitative eDNA Measurement. Cells in 200 μL of biofilm-inducing medium
were grown as described above, and the resuspended biofilm cells (follow-
ing the wash step) were filtered by using 0.2-μm AcroPrep Advance 96-well
filter plates (no. 8019; Pall). To measure eDNA, 100 μL of the filtered
resuspension was then mixed with 100 μL of 2 μM SYTOX Green (no. S7020;
ThermoFisher) solution in PBS to a final concentration of 1 μM in 200 μL (50).
Fluorescence was measured by using a plate reader (Infinite 200 Pro, Tecan)
with excitation and emission wavelengths of 465 nm and 510 nm, respec-
tively, and the amount of eDNA present relative to wild-type HG003
was calculated.
DNase Test Agar Plating. Overnight cultures were grown in TSB, and 10-μL
aliquots were spotted onto DNase test agar plates (no. 263220; Difco). Plates
were incubated at 37 °C overnight, flooded with 1 M HCl, and imaged.
Visualizing Cell Clumping. Preparation of samples was performed as described
(6). Following the centrifugation step to concentrate cells, pellets were im-
aged. Wild-type, DNase I-treated, and mutant cells were resuspended by
using the same number of pipetting steps. Higher magnification images
were taken with an Olympus BX61 microscope by using a 100×/1.3 N.A.
objective, whereas lower magnification images were taken with a Leica
DM5500 B microscope by using a 10×/0.3 N.A. objective.
Congo Red Assay. Congo red susceptibility assays were performed by spotting
10-fold dilutions of overnight cultures onto TSB agar and TSB agar supple-
mented with 0.1% or 0.06% (wt/vol) Congo red, as indicated. For strains
containing pASD135 or pASD145, erythromycin was included. For strains
containing pASD132 or pASD133, chloramphenicol was included. Plates were
incubated at 37 °C overnight and imaged.
Congo Red-Resistant Mutant Isolation. Dilutions of the transposon insertion
library from the initial transposon insertion screen were plated onto TSB agar
supplemented with 0.25% (wt/vol) Congo red. Resistant mutants were iso-
lated, and sites of insertion were determined by using random nested primer
amplification with Rnd1 primers followed by Rnd2 primers, followed by
sequencing (51). The specific site of insertion was determined by sequencing
a PCR product amplified by using a gene-specific primer (ASD227-R-1) and a
transposon-specific primer (ASD252). See Table S3 for primer sequences.
RNA Isolation. Dilutions of overnight cultures (1:1,000) were used as the in-
oculum for all samples. Exponential-phase cultures were grown in shaking
conditions at 37 °C to an OD600 of 0.5 in either TSB or TSB adjusted to pH 5.5.
Biofilms were grown in static conditions at 37 °C in TSB-G for 6 h, medium
was then removed and biofilm cells were scraped off in PBS without a wash
step. Samples were collected by using the RNAprotect Bacteria Reagent
(no. 76506; Qiagen) and snap frozen. RNA was isolated by adding 1 mL of
TRIzol reagent (no. 1559026, ThermoFisher) to each sample and lysing cells
by using a FastPrep (MP Biomedicals) for three 1-min pulses with 2- to 3-min
incubations on ice in between. After lysis, 200 μL of chloroform was added to
each sample, samples were vortexed for 1 min, incubated for 5 min at room
temperature and centrifuged at 20,000 × g for 5 min. The top phase was
then collected, 500 μL of isopropanol was added to it, samples were mixed
by inverting, incubated 10 min at room temperature, and centrifuged at
18,000 × g for 20 min at 4 °C. Pellets were than washed with 500 μL of 75%
ethanol, centrifuged at 18,000 × g for 5 min at 4 °C, and pellets were air
dried and resuspended in 150 μL of water. These samples were then treated
with DNase I (04716728001; Roche) according to manufacturer’s guidelines
and purified by using the RNeasy RNA cleanup protocol (Qiagen).
RNA-Seq Library Preparation. Throughout, RNA was either precipitated with
50% isopropanol, 150 mM sodium acetate pH 5.5, and 30 μg of GlycoBlue
Coprecipitant (ThermoFisher) for 30 min at −80 °C or cleaned by using a
Zymogen RNA Clean & Concentrator-5 as indicated, and RNA was excised
from polyacrylamide gels by using the ZR small-RNA PAGE recovery kit (Zy-
mogen). Samples for denaturing polyacrylamide gel electrophoresis were
prepared by using Novex-TBE-Urea sample buffer (Life Technologies) and
treated for 2 min at 80 °C.
For the sequencing library, total RNA (5–10 μg) was depleted of rRNA by using
MICROBExpress (ThermoFisher). RNA depleted of rRNA was precipitated and
resuspended into 40 μL of 10 mM Tris·HCl at pH 8.0. The RNAwas fragmented by
first heating the sample to 95 °C for 2 min and adding RNA fragmentation
buffer (1×, ThermoFisher) for 1 min at 95 °C and quenched by adding RNA
fragmentation stop buffer (ThermoFisher). Fragmented RNAs between 20 and
40 bp were isolated by size excision from a denaturing polyacrylamide gel
(15%, TBE-Urea, 65 min., 200 V, Life Technologies). Size-selected fragments
were dephosphorylated by using T4 polynucleotide kinase (New England
Biolabs), cleaned up, and ligated to 5′ adenylated and 3′-end blocked linker
1 (/5rApp/CTGTAGGCACCATCAAT/3ddc, IDT) by using T4 RNA ligase 2, trun-
cated K227Q (New England Biolabs). The ligation was carried out at 25 °C
for 2.5 h by using 5 pmol of dephosphorylated RNA in the presence of
25% PEG 8000 and Superase-In (ThermoFisher). Ligation products from 35 to
65 bp were excised after denaturing PAGE (10% TBE-Urea, 50 min, 200 V,
Life Technologies). cDNA was prepared by reverse transcription of ligated
RNA by using SuperScript III (Life Technologies) at 50 °C for 30 min with
primer oCJ485 (/5Phos/AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT/iSp18/
CAAGCAGAAGACGGCATACGAGATATTGATGGT, IDT) and isolated by size ex-
cision (10% TBE-Urea, 200 V, 80 min, Life Technologies). Single-stranded
cDNA was circularized by using CircLigase (Illumina) at 60 °C for 2 h. cDNA
was amplified by using Phusion DNA polymerase (New England Biolabs) with
primer o231 (CAAGCAGAAGACGGCATACGA, IDT) and indexing primer
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(AATGATACGGCGACCACCGAGATCGGAAGAGCACACGTCTGAACTCCAGTCA-
CNNNNNNCGACAGGTTCAGAGTTC, IDT). After 6–10 rounds of PCR amplifi-
cation, the product was selected by size from a nondenaturing PAGE (8% TB,
45 min, 180 V, Life Technologies).
RNA-Seq and Data Analysis. Sequencing was performed at the MIT BioMicro
Center on a HiSEq 2000 with 50-bp single-end reads. FASTQ files of sequence
data were processed by removing linker sequence, demultiplexing, and
mapping to the NCTC 8325 genome (NCBI Reference Sequence: NC_007795.1)
by using bowtie. The resulting SAM files were then imported into Geneious
(in all cases, v. 9.0.5 was used), where expression levels were calculated.
Identification of differentially expressed genes was also performed within
Geneious, where transcripts were normalized by total count excluding upper
quartile. This normalizationmethodwas chosenbecause of the variability in rRNA
depletion from sample to sample. We used a cutoff of an absolute log2-fold
change of greater than 1.5 and a confidence value of 10 or above (This value
represents the negative log10 of the P value).
qRT-PCR. cDNA was synthesized with 5 μg of RNA after DNase I treatment (see
above) by using random hexamers (ThermoFisher) and SuperScript III reverse
transcriptase (RT; Life Technologies) according to manufacturer’s guidelines. In
negative control reactions, RT was omitted. Only samples with at least 10 cy-
cles difference between samples with and without RT were analyzed. qRT-PCR
was performed by using SYBR FAST Universal One-Step qRT-PCR Kit (KAPA
Biosystems) with initial denaturation at 95 °C for 10 min, 40 cycles: 95 °C for
15 s, 53 °C for 15 s, 72 °C for 20 s followed by melting curve analysis with 95 °C
for 15 s, 60 °C for 15 s, and a final temperature increase to 95 °C over 10 min.
Primer pairs for genes tested are listed in Table S3. Data analysis was per-
formed according to Pfaffl (52), with hu used for normalization (53).
HPLC. Overnight cultures of S. aureus were grown in TSB and diluted
1:1,000 into fresh TSB or TSB-G. Cultures were grown with shaking at 37 °C
for the durations indicated, and samples were prepared for analysis as de-
scribed for c-di-GMP (54). Briefly, cell pellets were washed twice with cold
molecular grade water (Corning). Cell pellets were then resuspended in 50 μL
of molecular grade water containing 100 pg of c-di-GMP (used as an internal
standard). Cells were lysed by using 14.1 μL of cold 70% perchloric acid
(Sigma-Aldrich) and incubated on ice for 30 min. After incubation, the
samples were centrifuged at 21,000 × g for 5 min. Supernatants were re-
moved and neutralized with 32.8 μL of 2.5 M KHCO3 (Sigma Aldrich),
whereas pellets were washed with acetone and used later for protein
analysis. Once neutralized, samples were centrifuged at 21,000 × g for 5 min.
The supernatant was then removed and stored at −80 °C until HPLC analysis.
cyclic-di-AMP and ci-di-GMP standards (Sigma-Aldrich) were treated the
same as the samples. Samples were run similar to c-di-GMP (51) on an Agi-
lent 1100 HPLC-UV and peaks were quantified at 260 nm. Separation was
carried out by using a reverse-phase C18 Targa column (2.1 × 40 mm; 5 μm)
with a flow rate of 0.2 mL/min by using the following buffers and gradient:
buffer A (10 mM of ammonium acetate in water) and buffer B (10 mM of
ammonium acetate in methanol) for 0–9 min (99% buffer A, 1% buffer B),
9–14 min (15% buffer B), 14–19 min (25% buffer B), 19–26 min (90% buffer
B), and 26–40 min (1% buffer B). Protein pellets were resuspended in 50 mM
Tris pH 8.0, 6 M urea, 0.05% SDS, and measured by using a BCA kit (Pierce).
cyclic-di-AMP levels were normalized to protein amount.
Statistical Analysis. Statistical analysis was performed with GraphPad Prism 7.
Unpaired two-tailed Student’s t tests were performed, and the levels of
significance are indicated in the figure legends.
ACKNOWLEDGMENTS. We thank A. Gründling for strain ANG1958, MIT Bio-
Micro Center for RNA-seq work, the Harvard Bauer Core for HPLC access, the
Tufts University Core Facility for sequencing work and for access to their
Galaxy server, and L. Foulston and V. Dengler for advice on the manuscript.
Funding for this work was provided by NIH Grant P01-AI083214, an NSF
Graduate Research Fellowship Program Fellowship (to A.S.D.), by the Searle
Scholars Program and the Sloan Research Fellowship (to G-W L.), and NIH
Grant GM18568 (to R.L.).
1. Conlon BP (2014) Staphylococcus aureus chronic and relapsing infections: Evidence of
a role for persister cells: An investigation of persister cells, their formation and their
role in S. aureus disease. BioEssays 36:991–996.
2. Stewart PS (2015) Antimicrobial tolerance in biofilms. Microbiol Spectr 3, 10.1128/
microbiolspec.MB-0010-2014.
3. McCarthy H, et al. (2015) Methicillin resistance and the biofilm phenotype in Staph-
ylococcus aureus. Front Cell Infect Microbiol 5:1.
4. Herbert S, et al. (2010) Repair of global regulators in Staphylococcus aureus 8325 and
comparative analysis with other clinical isolates. Infect Immun 78:2877–2889.
5. Foulston L, Elsholz AK, DeFrancesco AS, Losick R (2014) The extracellular matrix of
Staphylococcus aureus biofilms comprises cytoplasmic proteins that associate with the
cell surface in response to decreasing pH. MBio 5:e01667-14.
6. Dengler V, Foulston L, DeFrancesco AS, Losick R (2015) An electrostatic net model for
the role of extracellular DNA in biofilm formation by Staphylococcus aureus.
J Bacteriol 197:3779–3787.
7. Boles BR, Thoendel M, Roth AJ, Horswill AR (2010) Identification of genes involved in
polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:
e10146.
8. Webb JS, et al. (2003) Cell death in Pseudomonas aeruginosa biofilm development.
J Bacteriol 185:4585–4592.
9. Renelli M, Matias V, Lo RY, Beveridge TJ (2004) DNA-containing membrane vesicles of
Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiology
150:2161–2169.
10. Salgado-Pabón W, et al. (2010) Increased expression of the type IV secretion system in
piliated Neisseria gonorrhoeae variants. J Bacteriol 192:1912–1920.
11. Santiago M, et al. (2015) A new platform for ultra-high density Staphylococcus aureus
transposon libraries. BMC Genomics 16:252.
12. Mann EE, et al. (2009)Modulation of eDNA release and degradation affects Staphylococcus
aureus biofilm maturation. PLoS One 4:e5822.
13. Valentino MD, et al. (2014) Genes contributing to Staphylococcus aureus fitness in
abscess- and infection-related ecologies. MBio 5:e01729-14.
14. Weng M, Nagy PL, Zalkin H (1995) Identification of the Bacillus subtilis pur operon
repressor. Proc Natl Acad Sci USA 92:7455–7459.
15. Corrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A (2011) c-di-AMP is a new
second messenger in Staphylococcus aureus with a role in controlling cell size and
envelope stress. PLoS Pathog 7:e1002217.
16. Seidl K, et al. (2009) Effect of a glucose impulse on the CcpA regulon in Staphylococcus
aureus. BMC Microbiol 9:95.
17. Pagels M, et al. (2010) Redox sensing by a Rex-family repressor is involved in the
regulation of anaerobic gene expression in Staphylococcus aureus. Mol Microbiol 76:
1142–1161.
18. Wu Y, et al. (2015) Staphylococcus epidermidis SrrAB regulates bacterial growth and
biofilm formation differently under oxic and microaerobic conditions. J Bacteriol 197:
459–476.
19. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS (2008) Factors contributing to
the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One 3:
e3361.
20. Beenken KE, et al. (2010) Epistatic relationships between sarA and agr in Staphylococcus
aureus biofilm formation. PLoS One 5:e10790.
21. Rupp ME, Archer GL (1992) Hemagglutination and adherence to plastic by Staphylococcus
epidermidis. Infect Immun 60:4322–4327.
22. Lipke PN, Wojciechowicz D, Kurjan J (1989) AG α 1 is the structural gene for the
Saccharomyces cerevisiae α-agglutinin, a cell surface glycoprotein involved in cell-cell
interactions during mating. Mol Cell Biol 9:3155–3165.
23. Suzuki T, et al. (2012) Wall teichoic acid protects Staphylococcus aureus from in-
hibition by Congo red and other dyes. J Antimicrob Chemother 67:2143–2151.
24. Ender M, Berger-Bächi B, McCallum N (2009) A novel DNA-binding protein modu-
lating methicillin resistance in Staphylococcus aureus. BMC Microbiol 9:15.
25. McCallum N, Hinds J, Ender M, Berger-Bächi B, Stutzmann Meier P (2010) Transcrip-
tional profiling of XdrA, a new regulator of spa transcription in Staphylococcus au-
reus. J Bacteriol 192:5151–5164.
26. Truong-Bolduc QC, Dunman PM, Strahilevitz J, Projan SJ, Hooper DC (2005) MgrA is a
multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 187:
2395–2405.
27. Utaida S, et al. (2003) Genome-wide transcriptional profiling of the response of
Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon.
Microbiology 149:2719–2732.
28. Dengler V, Meier PS, Heusser R, Berger-Bächi B, McCallum N (2011) Induction kinetics
of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall
active antibiotics. BMC Microbiol 11:16.
29. Truong-Bolduc QC, Hooper DC (2007) The transcriptional regulators NorG and MgrA
modulate resistance to both quinolones and β-lactams in Staphylococcus aureus.
J Bacteriol 189:2996–3005.
30. Wang R, et al. (2007) Identification of novel cytolytic peptides as key virulence de-
terminants for community-associated MRSA. Nat Med 13:1510–1514.
31. Beaume M, et al. (2010) Cartography of methicillin-resistant S. aureus transcripts:
Detection, orientation and temporal expression during growth phase and stress
conditions. PLoS One 5:e10725.
32. Abu-Qatouseh LF, et al. (2010) Identification of differentially expressed small non-
protein-coding RNAs in Staphylococcus aureus displaying both the normal and the
small-colony variant phenotype. J Mol Med (Berl) 88:565–575.
33. Howden BP, et al. (2013) Analysis of the small RNA transcriptional response in
multidrug-resistant Staphylococcus aureus after antimicrobial exposure. Antimicrob
Agents Chemother 57:3864–3874.
34. Rice KC, et al. (2007) The cidA murein hydrolase regulator contributes to DNA release
and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA 104:
8113–8118.
DeFrancesco et al. PNAS | Published online July 3, 2017 | E5977
M
IC
RO
BI
O
LO
G
Y
PN
A
S
PL
U
S
35. Heilmann C, Hartleib J, Hussain MS, Peters G (2005) The multifunctional Staphylo-
coccus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fi-
bronectin. Infect Immun 73:4793–4802.
36. Bose JL, Lehman MK, Fey PD, Bayles KW (2012) Contribution of the Staphylococcus
aureus Atl AM and GL murein hydrolase activities in cell division, autolysis, and bio-
film formation. PLoS One 7:e42244.
37. Mashruwala AA, Guchte AV, Boyd JM (2017) Impaired respiration elicits SrrAB-dependent
programmed cell lysis and biofilm formation in Staphylococcus aureus. eLife 6:6.
38. Griffiths JM, O’Neill AJ (2012) Loss of function of the gdpP protein leads to joint
β-lactam/glycopeptide tolerance in Staphylococcus aureus. Antimicrob Agents
Chemother 56:579–581.
39. Corrigan RM, Bowman L, Willis AR, Kaever V, Gründling A (2015) Cross-talk between
two nucleotide-signaling pathways in Staphylococcus aureus. J Biol Chem 290:
5826–5839.
40. Luo Y, Helmann JD (2012) Analysis of the role of Bacillus subtilis σ(M) in β-lactam
resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol
Microbiol 83:623–639.
41. Boles BR, Horswill AR (2008) Agr-mediated dispersal of Staphylococcus aureus bio-
films. PLoS Pathog 4:e1000052.
42. Periasamy S, et al. (2012) How Staphylococcus aureus biofilms develop their charac-
teristic structure. Proc Natl Acad Sci USA 109:1281–1286.
43. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR (2012) Functional amyloids
composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS
Pathog 8:e1002744.
44. Onyango LA, Dunstan RH, Gottfries J, von Eiff C, Roberts TK (2012) Effect of low tem-
perature on growth and ultra-structure of Staphylococcus spp. PLoS One 7:e29031.
45. Maduka-Ezeh AN, et al. (2012) Antimicrobial susceptibility and biofilm formation of
Staphylococcus epidermidis small colony variants associated with prosthetic joint in-
fection. Diagn Microbiol Infect Dis 74:224–229.
46. DeJesus MA, Ambadipudi C, Baker R, Sassetti C, Ioerger TR (2015) TRANSIT–A soft-
ware tool for Himar1 TnSeq analysis. PLOS Comput Biol 11:e1004401.
47. Kato F, Sugai M (2011) A simple method of markerless gene deletion in Staphylo-
coccus aureus. J Microbiol Methods 87:76–81.
48. Pang YY, et al. (2010) agr-Dependent interactions of Staphylococcus aureus
USA300 with human polymorphonuclear neutrophils. J Innate Immun 2:546–559.
49. Monk IR, Shah IM, Xu M, Tan MW, Foster TJ (2012) Transforming the untransformable:
Application of direct transformation to manipulate genetically Staphylococcus aureus
and Staphylococcus epidermidis. MBio 3:e00277-11.
50. Iyer VS, Hancock LE (2012) Deletion of σ(54) (rpoN ) alters the rate of autolysis and
biofilm formation in Enterococcus faecalis. J Bacteriol 194:368–375.
51. Cabeen MT, Leiman SA, Losick R (2016) Colony-morphology screening uncovers a role
for the Pseudomonas aeruginosa nitrogen-related phosphotransferase system in bi-
ofilm formation. Mol Microbiol 99:557–570.
52. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res 29:e45.
53. Valihrach L, Demnerova K (2012) Impact of normalization method on experimental
outcome using RT-qPCR in Staphylococcus aureus. J Microbiol Methods 90:214–216.
54. Jones CJ, et al. (2014) ChIP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for
cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa. PLoS
Pathog 10:e1003984.
55. Kreiswirth BN, et al. (1983) The toxic shock syndrome exotoxin structural gene is not
detectably transmitted by a prophage. Nature 305:709–712.
E5978 | www.pnas.org/cgi/doi/10.1073/pnas.1704544114 DeFrancesco et al.
